9 completed, 4 unknown, 2 recruiting, 1 enrolling by invitation. 11 Not applicable, 2 Phase 3, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 11 | Completed 7, Unknown 2, Enrolling by invitation 1, Recruiting 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Proto-Oncogene Proteins c-raf: new trials by email Literature Review of Proto-Oncogene Proteins c-raf trials Research Report on Proto-Oncogene Proteins c-raf
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Collaborative Opportunities for Reducing Alcohol and Sexual Violence Together Peer-Based Motivational Interview, Health and Well-Being for All - Sexual Violence, Behavior Change | Not applicable | Recruiting | State University of New York at Buffalo | 132 | 2025-10-10 | 2026-04-23 |
| Efficacy of New Trio Combination for Melasma New trio combination, Kligman's formula (trio) - Melasma | Phase 4 | Completed | Ghurki Trust and Teaching Hospital | 56 | 2025-05-07 | 2026-06-30 |
| Online Video Training for Teachers to Improve Reading Skills in Children Using Augmentative and Alternative Communication Online Video training for Teachers based on Reading for all - Autism, Intellectual Disabilities | Not applicable | Enrolling by invitation | Ostfold University College | 70 | 2024-11-25 | 2025-02-19 |
| Mindfulness Intervention to Reduce Low Back Pain Among Academicians Mindfulness for All - Low Back Pain | Not applicable | Unknown | Universiti Sains Malaysia | 86 | 2024-03-01 | 2024-01-22 |
| A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer MBQ-167 - Breast Cancer, Breast Neoplasm | Phase 1 | Recruiting | MBQ Pharma | 48 | 2023-11-09 | 2026-08-31 |
| Investigation of Medical Management to Prevent Episodes of Diverticulitis Trial Medi for All, Standard Fiber Supplementation - Diverticulitis | Not applicable | Completed | University of Washington | 71 | 2023-01-01 | 2026-06-12 |
| WOOP VA: Promoting Weight Management in Primary Care mental contrasting with implementation intentions, telephone-delivered, telehealth-delivered, and or in-person MOVE! or TeleMOVE!, Information About Diet, Physical Activity, and Weight Management (Baseline Visit - 10 minutes): All - Obesity | Not applicable | Completed | VA Office of Research and Development | 405 | 2022-02-15 | 2026-05-20 |
| Active and Healthy Ageing for All: a Multi-component Healthy Lifestyle Program AHAA - Health Promotion | Not applicable | Unknown | KU Leuven | 400 | 2019-09-01 | 2022-07-21 |
| Increasing Individualism and Collectivism Online prime (statements writing), Online prime (circling), Online prime (Sumarian Warrior) - Individual Difference | Not applicable | Completed | Yale-NUS College | 495 | 2017-09-17 | 2018-02-13 |
| A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3) Ruxolitinib, Extracorporeal photopheresis (ECP), Low-dose methotrexate (MTX) - Graft-versus-host Disease (GVHD) | Phase 3 | Completed | Incyte Corporation | 330 | 2017-06-29 | 2025-08-12 |
| Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy Volumetric Arc Radiotherapy, Interstitial brachytherapy, Cisplatin - Cervical Cancer | Phase 3 | Unknown | The National Center of Oncology, Azerbaijan | 400 | 2015-03-01 | 2016-11-15 |
| Early Access to ART for All in Swaziland: Effects on Economic Outcomes Early Access to ART for All - HIV/AIDS | Not applicable | Completed | Till Bärnighausen | 3019 | 2014-09-01 | 2019-01-04 |
| MaxART: Early Access to ART for All in Swaziland Early Access to ART for All - HIV/AIDS | Not applicable | Completed | Clinton Health Access Initiative Inc. | 3485 | 2014-09-01 | 2018-07-18 |
| StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study PSE 120 mg, CM 8 mg, Atr 0.36 mg, PSE 120 mg, CM 8 mg, Atr 0.24 mg, PSE 120 mg, CM 8 mg, Atr 0.12 mg - Rhinitis, Seasonal, Allergic | Phase 2 | Unknown | Magna Pharmaceuticals, Inc. | 125 | 2014-03-01 | 2014-05-30 |
| Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication Sequential therapy, Quadruple therapy - Helicobacter Pylori Infection | Not applicable | Completed | The University of Hong Kong | 391 | 2011-05-01 | 2013-01-04 |
| Trial of Low and High Intensity Strategies to Maintain BP Control High Intensity Intervention, Low Intensity Intervention, All- 6 month pharmacist intervention - Hypertension | Not applicable | Completed | US Department of Veterans Affairs | 249 | 2009-11-01 | 2015-04-27 |
Acquired Immunodeficiency Syndrome (2) · Anxiety Disorders (1) · Autistic Disorder (1) · Breast Neoplasms (1) · Bronchiolitis Obliterans Syndrome (1) · Depression (1) · Diverticulitis (1) · Graft vs Host Disease (1) · Hypertension (1) · Infections (1) · Intellectual Disability (1) · Low Back Pain (1) · Melanosis (1) · Obesity (1) · Rhinitis (1)
Clinton Health Access Initiative Inc. (1) · Ghurki Trust and Teaching Hospital (1) · Incyte Corporation (1) · KU Leuven (1) · MBQ Pharma (1) · Magna Pharmaceuticals, Inc. (1) · Ostfold University College (1) · State University of New York at Buffalo (1) · The National Center of Oncology, Azerbaijan (1) · The University of Hong Kong (1) · Till Bärnighausen (1) · US Department of Veterans Affairs (1) · Universiti Sains Malaysia (1) · University of Washington (1) · VA Office of Research and Development (1)
United States (7) · Belgium (2) · Norway (2) · Puerto Rico (2) · Australia (1) · Austria (1) · Azerbaijan (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Denmark (1) · Eswatini (1) · France (1) · Germany (1) · Greece (1)
David R Flum, MD, MPH (1) · Dr Aliza Hamadani (1) · Dr. Ayesha Asad Chattha (1) · Dr. Iram Kausar (1) · Dr. Meshaal Azhar (1) · Eva N Zamri, PhD (1) · Gary E. Rosenthal, MD (1) · Hugo Cogo Moreira, Professor (1) · Ivan FN Hung, MD FRCP (1) · Jennifer P Read, Ph.D. (1) · Julie Vanderlinden, PHDc (1) · Kamal Akbarov, PhD (1) · Melanie R. Jay, MD MS (1) · Neil Sankar, MD (1) · Prof. Dr. Haroon Nabi (1)
PMID 32831169, PMID 33074097, PMID 33107430, PMID 23730989, PMID 24295850, PMID 24373519, PMID 24398076, PMID 24588813, PMID 26032843, PMID 28821264, PMID 29316837, PMID 34260836, PMID 35363318, PMID 38608752, PMID 40472328, PMID 40561385, PMID 41671743, PMID 42180389
2016 (1), R01DK131694 (1)